Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Help & FAQ
Link opens in a new tab
Search content at Houston Methodist Scholars
Home
Experts
Research units
Research output
Prizes
Rivastigmine for subcortical vascular dementia
Gustavo C. Roman
Stanley H. Appel Department of Neurology
Academic Institute
Nantz National Alzheimer Center
Neurological Institute
Houston Methodist Hospital
Houston Methodist
Weill Cornell Medical College
Research output
:
Contribution to journal
›
Review article
›
peer-review
14
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rivastigmine for subcortical vascular dementia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Rivastigmine
100%
Subcortical Ischemic Vascular Disease
100%
Alzheimer's Disease
33%
Moderate to Severe
16%
Acetylcholinesterase Inhibitors (AChEI)
16%
Activities of Daily Living
16%
Vascular Dementia
16%
Alzheimer's Dementia
16%
Dementia with Lewy Bodies
16%
Executive Function
16%
Apathy
16%
Placebo-controlled Clinical Trial
16%
Neuropsychiatric Manifestations
16%
Drug Profile
16%
Behavioral Manifestations
16%
Acetylcholinesterase and Butyrylcholinesterase
16%
Behavioral Deficits
16%
Medicine and Dentistry
Vascular Dementia
100%
Rivastigmine
100%
Alzheimer's Disease
50%
Placebo
16%
Diffuse Lewy Body Disease
16%
Controlled Clinical Trial
16%
Acetylcholinesterase Inhibitor
16%
Acetylcholinesterase
16%
Executive Function
16%
Drug Analysis
16%
Neuroscience
Vascular Dementia
100%
Rivastigmine
100%
Alzheimer's Disease
50%
Placebo
16%
Acetylcholinesterase Inhibitor
16%
Dementia with Lewy Body
16%
Executive Function
16%
Acetylcholinesterase
16%
Pharmacology, Toxicology and Pharmaceutical Science
Multiinfarct Dementia
100%
Rivastigmine
100%
Alzheimer's Disease
50%
Placebo
16%
Cholinesterase Inhibitor
16%
Controlled Clinical Trial
16%
Acetylcholinesterase
16%
Diffuse Lewy Body Disease
16%
Biochemistry, Genetics and Molecular Biology
Butyrylcholinesterase
100%
Acetylcholinesterase
50%
Executive Function
50%
Cholinesterase
50%
Controlled Clinical Trial
50%